DaVita
DVA
#1949
Rank
C$13.84 B
Marketcap
C$207.04
Share price
1.19%
Change (1 day)
-5.15%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): C$14.03

According to DaVita's latest financial reports the company's current EPS (TTM) is C$13.73. In 2024 the company made an earnings per share (EPS) of C$14.97 an increase over its 2023 EPS that were of C$10.33.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$14.03-6.3%
2024C$14.9744.94%
2023C$10.3327.26%
2022C$8.12-35.56%
2021C$12.5944.1%
2020C$8.7419.7%
2019C$7.30540.48%
2018C$1.14-76.07%
2017C$4.76-19.31%
2016C$5.90242.52%
2015C$1.72-62.87%
2014C$4.6413.43%
2013C$4.098.45%
2012C$3.77

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
C$28.97 110.97%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$13.91 1.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
C$19.95 45.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
C$2.58-81.24%๐Ÿ‡บ๐Ÿ‡ธ USA